Loading clinical trials...
Loading clinical trials...
Prospective, Multi-center, Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Conditions
Start Date
November 1, 2015
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
February 24, 2017
NCT06823947
NCT05507879
NCT04551560
NCT07101289
NCT03994874
NCT04100148
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions